News
Amgen and UCB Team Up with NASA on Final Space Shuttle Mission
Amgen (NASDAQ: AMGN) and UCB (Euronext Brussels: UCB) are collaborating with the National Aeronautics and Space Administration (NASA) Ames Research Center to conduct a preclinical test of a sclerostin antibody in an experiment that will take place aboard space...
News
Medical Research Council Finds Antibody Capable of Fighting Flu
An antibody that can fight all types of the influenza A virus has been identified by researchers from the Medical Research Council's National Institute for Medical Research. Studies in fly-infected mice showed that the antibody could...
News
GlaxoSmithKline and Valeant announce US FDA approval of Potiga
GlaxoSmithKline and Valeant Pharmaceuticals International, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Potiga™ (ezogabine) Tablets, a potassium channel opener, as adjunctive treatment of partial-onset seizures in patients aged 18 years and older. ...
News
Paladin And Elan Sign Agreement For New Pain Product
Paladin Labs Inc., a leading Canadian specialty pharmaceutical company, today announced that they have entered into a licensing and distribution agreement under which Paladin has been granted exclusive Canadian rights from an affiliate of Elan Corporation,.. ...
News
Merck Statement Regarding FDA Approval of Changes to Trade Packaging Design
Merck appreciates the U.S. Food and Drug Administration's (FDA) recognition of our efforts to create new standardized product packaging for several of our medicines. These changes to the packaging of several medicines were made by Merck...
News
Synthes and Lilly Sign Development and Collaboration Agreement
Synthes, Inc. and Eli Lilly and Company announced the signing of an exclusive worldwide collaboration agreement to address the needs of patients who are cared for by orthopedic surgeons, including those with osteoporosis and those with bone fractures. ...
News
Forest Laboratories, Inc. Announces Availability of Daliresp(TM) in Pharmacies
Forest Laboratories, Inc. announced today that Daliresp(TM) (roflumilast) will be available in pharmacies throughout the United States by mid-June. The U.S. Food and Drug Administration (FDA) recently approved Daliresp as a treatment to reduce the risk...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.